|
PF-50319 |
CEUMID XR 1000 Comprimidos recubiertos de liberación prolongada |
2024-07-15 |
|
Megapharma Labs de Ceam, Sociedad Anónima |
Uruguay
|
Leterago |
Codalo |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-50478 |
DEXLANZOPRAL 60, 60 mg Capsulas con microgránulos gastrorresistentes_x000D_
|
2024-08-01 |
|
Roemmers S.A. |
Uruguay
|
Leterago |
Codalo |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-50455 |
DEXLANZOPRAL 30, 30 mg. Cápsulas con microgránulos gastrorresistentes |
2024-07-30 |
|
Roemmers, S.A. |
Uruguay
|
Leterago |
Codalo |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51277 |
CEUMID 500 mg/5 mL Concentrado para solución para perfusión |
2025-01-29 |
|
Megapharma Labs de Ceam, Sociedad Anónima |
Uruguay
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51661 |
MARTESIA 75, 75 mg Comprimidos dividosis |
2025-07-22 |
|
Megapharma Labs de Ceam, Sociedad Anónima |
Uruguay
|
Leterago |
Codalo |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51855 |
ILIMIT 1 mg/mL Solución oral |
2025-05-14 |
|
Megapharma Labs de Ceam, Sociedad Anónima |
Uruguay
|
Leterago |
Codalo |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52537 |
POLILAX Polvo para solución oral |
2026-02-08 |
|
Megalabs Uruguay S.A. |
Uruguay
|
Leterago |
Codalo |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-53327 |
LOGICAL 0.1% Solución oral (gotas) |
2026-10-13 |
|
Megapharma Labs de Ceam, Sociedad Anónima |
Uruguay
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-53471 |
LEVITAL 20 Comprimidos recubiertos |
2026-07-08 |
|
Panalab |
Uruguay
|
Leterago |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54139 |
NEURONAL 75, 75 mg Comprimidos dividosis |
2022-06-08 |
|
Panalab S.A. |
Uruguay
|
Leterago |
Codalo |
Panalab |
Direca |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|